Page last updated: 2024-11-05

alpha-methylepinephrine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Alpha-methylepinephrine (α-methyl-epinephrine) is a synthetic catecholamine that acts as an adrenergic agonist. It is structurally similar to epinephrine, but with a methyl group added to the alpha carbon atom. This modification results in a compound with a longer duration of action and a greater potency compared to epinephrine. It has been studied for its potential therapeutic applications in treating conditions such as asthma, hypotension, and cardiac arrest. Its synthesis involves chemical modification of epinephrine. The effects of α-methyl-epinephrine include vasoconstriction, bronchodilation, and an increase in heart rate and blood pressure. Its importance lies in its ability to stimulate both alpha and beta adrenergic receptors, leading to a diverse range of physiological responses. Research on α-methyl-epinephrine focuses on understanding its pharmacological properties, potential therapeutic uses, and potential side effects. Further research is needed to determine its optimal dosage and safety profile for various clinical applications.'

alpha-methylepinephrine: RN given refers to cpd without isomeric designation; structure in Negwer, 5th ed, #1401 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID13683
CHEMBL ID416557
SCHEMBL ID250137
MeSH IDM0093298

Synonyms (22)

Synonym
dioxyphedrine
dioxifedrine
dioxifedrin
CHEMBL416557
4-[1-hydroxy-2-(methylamino)propyl]benzene-1,2-diol
AKOS006271738
cf48qoh154 ,
dioxifedrinum [inn-latin]
alpha-methylepinephrine
dioxifedrinum
dioxifedrina
unii-cf48qoh154
einecs 233-716-9
dioxifedrine [inn]
dioxifedrina [inn-spanish]
3,4-dihydroxy-alpha-(1-(methylamino)ethyl)benzyl alcohol
10329-60-9
3,4-dihydroxy-.alpha.-(1-(methylamino)ethyl)benzyl alcohol
SCHEMBL250137
DTXSID40864249
bdbm50223427
Q27275430
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID37468Compound was evaluated for inhibition of [3H]prazosin binding to Alpha-1 adrenergic receptor in rat forebrain homogenate.1981Journal of medicinal chemistry, Oct, Volume: 24, Issue:10
(alpha S)-erythro-alpha-methylepinephrine: preparation and stereoselective binding to adrenergic receptors in rat forebrain.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (80.00)18.7374
1990's3 (20.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.41 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.31 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (11.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (88.24%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]